Merrill Lynch Br. SmallerCo Tst PLC
10 March 2005
MERRILL LYNCH BRITISH SMALLER COMPANIES TRUST plc
All information is at 28 February 2005 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value 4.2% 17.3% 22.5% 42.5% -7.2%
Share price 2.2% 14.6% 28.3% 46.9% -7.2%
FTSE Small Cap Index (ex IC's) 2.0% 9.9% 9.8% 29.5% 1.6%
Sources: Merrill Lynch Investment Managers and Datastream.
At month end
Net asset value: 281.87p
Share price: 229.00p
Discount to NAV: 18.8%
Net yield: 2.0%
Total assets: £159.0m
Gearing: 10.2%
Ordinary shares in issue: 51,163,523
Ten Largest Sector
Weightings % of Total Assets
Support Services 9.6
Software & Computer Services 9.5
Media & Entertainment 8.4
Construction & Building Materials 6.7
Leisure & Hotels 6.6
Mining 6.1
Oil & Gas 5.4
General Retailers 5.1
Engineering & Machinery 4.0
Speciality & Other Finance 4.0
----
Total 65.4
----
Ten Largest Equity Investments
Company % of Total Assets
Aveva Group 2.3
Brewin Dolphin 2.3
Consolidated Minerals 2.2
BSS Group 2.1
Blacks Leisure Group 2.0
Parkdean Holidays 2.0
Dechra Pharmaceuticals 2.0
Chaucer Holdings 1.8
Holidaybreak 1.7
Dicom Group 1.5
----
Total 19.9
----
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During February the Trust's NAV per share rose by 4.2% to 281.9 pence, compared
to a 2.0% increase in the benchmark index. The Trust's share price rose by 2.2%
to 229 pence. This was the sixth consecutive month of rises in the smallcap
sector.
Amongst larger holdings, strong share price performances were seen in
Consolidated Minerals, again, Burren Energy, SCS Upholstery, after confirming
strong trading post Christmas, ITE, Gooch and Housego, and Royalblue. Royalblue
management have been very cautious over the last few years, but talked of a
distinct improvement in the spending outlook for their investment banking
customers. At the smaller end, Subsea Resources shares were strong as it
confirmed it is on track to commence salvage from the first of the wrecks it has
identified.
Poor performances were seen by Plasmon and Huveaux. Plasmon has developed new
high capacity UDO storage drives and media, which are attracting significant
global interest from the likes of HP and IBM. However, sales through the key
reseller channels have been slower than hoped, but continue to build; we believe
medium term prospects remain attractive but the next 6 to 12 months will be hard
work. Huveaux announced that profits would be below market expectations.
However, the political publications business has a dominant market position and
should continue to do well long term. The principal problem lies with the
training business, and action is now, belatedly being taken to address this.
New holdings during the month included RPC, Brammer, Neutec Pharma, and First
Quantum. RPC management have an excellent long term record in the plastics
packaging industry, and are confident for various reasons, one of which is the
winning of some exciting new business with Kraft to make coffee capsules for use
with Tassimo coffee makers. Brammer, a former holding, having sold their
Livingstone business, are now focusing on their core business and trading
conditions are improving. Neutec Pharma is favoured by the MLIM UK team, and one
of few biotechnology stocks owned by the Trust. First Quantum is a copper
producer, with sharply increasing production and cash generation. The stock is
also owned by various other Merrill Lynch funds including those managed by the
World Mining team.
Various holdings have been trimmed during the month. The only complete sale was
of our small holding in Invox, after a disappointing update with management.
The Trust's strategy, gearing policy and confidence levels have not changed over
the month.
Latest information is available by typing www.mlim.co.uk/its on the internet,
'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal).
10 March 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.